Showing results (991-1000 of 1,555) with videos related to
Sort By:
Pageof 156
Clinical Immunology and Immunopathology|April 1, 1996
Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitroY Furukawa, A Matsumori, T Hirozane, et al.Cancer Research|November 1, 1979
Inhibitory effects of 9-beta-D-arabinofuranosylguanine 5'-triphosphate and 9-beta-D-arabinofuranosyladenine 5'-triphosphate on DNA polymerases from murine cells and oncornavirusK Ono, A Ohashi, A Yamamoto, et al.Radiation Medicine|January 1, 1997
Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumorsS Masunaga, K Ono, M Akaboshi, et al.Arzneimittel-Forschung|June 1, 1990
Disposition and effect of the new thromboxane synthetase inhibitor 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid in manM Tanaka, K Ono, H Hakusui, et al.Clinical Orthopaedics and Related Research|December 1, 1988
Nerve repairs for traumatic brachial plexus palsy with root avulsionH Kawai, H Kawabata, K Masada, et al.Clinical Orthopaedics and Related Research|September 1, 1988
Desmoplastic fibroma of the axis. A case reportT Fuji, H Hamada, T Masuda, et al.Cancer|December 1, 1988
Prognostic significance of mast cells in soft tissue sarcomaT Ueda, K Aozasa, M Tsujimoto, et al.The Journal of Rheumatology|May 1, 1989
Elevated activity of myeloid growth factor in bone marrow adjacent to joints affected by rheumatoid arthritisH Owaki, T Ochi, K Yamasaki, et al.The Journal of Pharmacy and Pharmacology|October 1, 1989
The pharmacokinetics and pharmacodynamics of a new thromboxane synthetase inhibitor, 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid (DP-1904), in man after single oral administrationM Tanaka, K Ono, T Takegoshi, et al.Neuroscience Research|September 18, 1997
A monoclonal antibody that recognizes ganglioside GD1b in the rat central nervous systemT Maehara, K Ono, K Tsutsui, et al.Pageof 156